Insider Trading disclosures for Immunovant Inc

The latest disclosure was made by Andrew J. Fromkin in Immunovant Inc where a trade of 6,616 Common Stock done at an average price of $19.5 was reported to US exchanges on March 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Andrew J. Fromkin	Director	Sale of securities on an exchange or to another person at price $ 19.52 per share.	07 Mar 2025	6,616	93,297 (0%)	0%	19.5	129,144	Common Stock
Andrew J. Fromkin	Director	Sale of securities on an exchange or to another person at price $ 19.96 per share.	07 Mar 2025	1,384	91,913 (0%)	0%	20.0	27,625	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 20.86 per share.	19 Feb 2025	15,439	948,786 (1%)	0%	20.9	322,058	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 20.86 per share.	19 Feb 2025	2,055	357,353 (0%)	0%	20.9	42,867	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 20.86 per share.	19 Feb 2025	2,814	321,952 (0%)	0%	20.9	58,700	Common Stock
Jay S. Stout	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 23.59 per share.	22 Jan 2025	2,195	139,991 (0%)	0%	23.6	51,780	Common Stock
Michael Geffner	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 23.59 per share.	22 Jan 2025	2,657	132,314 (0%)	0%	23.6	62,679	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 23.81 per share.	15 Jan 2025	8,352	964,640 (1%)	0%	23.8	198,861	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 24.19 per share.	15 Jan 2025	415	964,225 (1%)	0%	24.2	10,039	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 24.21 per share.	15 Jan 2025	19	359,408 (0%)	0%	24.2	460	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 24.19 per share.	15 Jan 2025	94	359,814 (0%)	0%	24.2	2,274	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 23.81 per share.	15 Jan 2025	387	359,427 (0%)	0%	23.8	9,214	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 23.81 per share.	15 Jan 2025	1,883	359,908 (0%)	0%	23.8	44,834	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 24.19 per share.	15 Jan 2025	109	324,766 (0%)	0%	24.2	2,637	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 23.81 per share.	15 Jan 2025	2,189	324,875 (0%)	0%	23.8	52,120	Common Stock
A. Christopher Van Tuyl	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2024	137,446	137,446	-		-	Stock Option (right to buy)
A. Van Tuyl Christopher	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2024	109,956	109,956 (0%)	0%		0	Common Stock
Pande Atul	Director	Sale of securities on an exchange or to another person at price $ 28.54 per share.	02 Dec 2024	7,750	86,663 (0%)	0%	28.5	221,185	Common Stock
J. Douglas Hughes	Director	Sale of securities on an exchange or to another person at price $ 28.54 per share.	02 Dec 2024	5,425	119,585 (0%)	0%	28.5	154,830	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 25.45 per share.	20 Nov 2024	3,650	319,228 (0%)	0%	25.5	92,893	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 25.45 per share.	20 Nov 2024	16,692	978,097 (1%)	0%	25.4	424,811	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 25.45 per share.	20 Nov 2024	3,353	361,791 (0%)	0%	25.5	85,334	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 25.45 per share.	20 Nov 2024	4,174	331,169 (0%)	0%	25.4	106,228	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 29.53 per share.	23 Oct 2024	4,361	322,878 (0%)	0%	29.5	128,780	Common Stock
Jay S. Stout	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 29.53 per share.	23 Oct 2024	2,740	142,186 (0%)	0%	29.5	80,912	Common Stock
Michael Geffner	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 29.53 per share.	23 Oct 2024	3,189	134,971 (0%)	0%	29.5	94,171	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 28.79 per share.	16 Oct 2024	2,860	327,239 (0%)	0%	28.8	82,339	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 28.79 per share.	16 Oct 2024	9,095	994,789 (1%)	0%	28.8	261,845	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 28.79 per share.	16 Oct 2024	2,627	365,705 (0%)	0%	28.8	75,631	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 28.79 per share.	16 Oct 2024	561	365,144 (0%)	0%	28.8	16,151	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 28.79 per share.	16 Oct 2024	3,271	335,343 (0%)	0%	28.8	94,172	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 29.56 per share.	09 Oct 2024	4,460	1,003,884 (1%)	0%	29.6	131,838	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 29.56 per share.	09 Oct 2024	5,162	338,614 (0%)	0%	29.6	152,589	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 31.84 per share.	21 Aug 2024	3,164	330,230 (0%)	0%	31.8	100,742	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 32.32 per share.	21 Aug 2024	131	330,099 (0%)	0%	32.3	4,234	Common Stock
Julia G. Butchko	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 31.84 per share.	21 Aug 2024	2,907	441,079 (0%)	0%	31.8	92,559	Common Stock
Julia G. Butchko	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 32.32 per share.	21 Aug 2024	120	440,959 (0%)	0%	32.3	3,878	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 32.32 per share.	21 Aug 2024	598	1,008,344 (1%)	0%	32.3	19,327	Common Stock
Peter Salzmann	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 31.84 per share.	21 Aug 2024	14,470	1,008,942 (1%)	0%	31.8	460,725	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 32.32 per share.	21 Aug 2024	120	368,332 (0%)	0%	32.3	3,878	Common Stock
William L. Macias	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 31.84 per share.	21 Aug 2024	2,907	368,452 (0%)	0%	31.8	92,559	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 32.32 per share.	21 Aug 2024	149	343,776 (0%)	0%	32.3	4,816	Common Stock
Eva Renee Barnett	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 31.84 per share.	21 Aug 2024	3,619	343,925 (0%)	0%	31.8	115,229	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 27.76 per share.	24 Jul 2024	4,015	333,394 (0%)	0%	27.8	111,456	Common Stock
Jay S. Stout	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 27.76 per share.	24 Jul 2024	2,813	144,926 (0%)	0%	27.8	78,089	Common Stock
Michael Geffner	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 27.76 per share.	24 Jul 2024	3,456	138,160 (0%)	0%	27.8	95,939	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 29.64 per share.	17 Jul 2024	2,358	337,556 (0%)	0%	29.6	69,891	Common Stock
Mark S. Levine	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 30.55 per share.	17 Jul 2024	147	337,409 (0%)	0%	30.6	4,491	Common Stock
Julia G. Butchko	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 29.64 per share.	17 Jul 2024	2,698	444,155 (0%)	0%	29.6	79,969	Common Stock
Julia G. Butchko	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 30.55 per share.	17 Jul 2024	169	443,986 (0%)	0%	30.6	5,163	Common Stock

Showing 1 to 50 of 346 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

Insider Trading disclosures for Immunovant Inc

The latest disclosure was made by Andrew J. Fromkin in Immunovant Inc where a trade of 6,616 Common Stock done at an average price of $19.5 was reported to US exchanges on March 7, 2025.

Screeners based on Insider Trading and SAST parameters